

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.30873461 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.30873461 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.16219419 |
| 4 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.06543739 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.86633443 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.79459376 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.72224060 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.58844167 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 4.39603247 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.39603247 |
| 11 | leukocyte aggregation (GO:0070486) | 4.33247747 |
| 12 | positive thymic T cell selection (GO:0045059) | 4.32116787 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.26709186 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.10645348 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 3.96763728 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.95484337 |
| 17 | L-phenylalanine catabolic process (GO:0006559) | 3.95484337 |
| 18 | thymic T cell selection (GO:0045061) | 3.94314824 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 3.88515854 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 3.88515854 |
| 21 | modulation by symbiont of host defense response (GO:0052031) | 3.88515854 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.88515854 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.88515854 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.88515854 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 3.86707772 |
| 26 | regulation of cholesterol homeostasis (GO:2000188) | 3.75045528 |
| 27 | detection of bacterium (GO:0016045) | 3.73829614 |
| 28 | cysteine metabolic process (GO:0006534) | 3.68497380 |
| 29 | glyoxylate metabolic process (GO:0046487) | 3.67901831 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 3.66120609 |
| 31 | detection of other organism (GO:0098543) | 3.65719154 |
| 32 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.63589056 |
| 33 | maternal placenta development (GO:0001893) | 3.63059005 |
| 34 | negative regulation of sterol transport (GO:0032372) | 3.61573865 |
| 35 | negative regulation of cholesterol transport (GO:0032375) | 3.61573865 |
| 36 | negative thymic T cell selection (GO:0045060) | 3.56091488 |
| 37 | T cell selection (GO:0045058) | 3.48756458 |
| 38 | regulation of gamma-delta T cell activation (GO:0046643) | 3.46904608 |
| 39 | mannose metabolic process (GO:0006013) | 3.46584363 |
| 40 | pentose-phosphate shunt (GO:0006098) | 3.46411793 |
| 41 | positive T cell selection (GO:0043368) | 3.46234828 |
| 42 | synaptic vesicle maturation (GO:0016188) | 3.44740304 |
| 43 | negative regulation of cell size (GO:0045792) | 3.44280078 |
| 44 | negative T cell selection (GO:0043383) | 3.39377370 |
| 45 | response to muramyl dipeptide (GO:0032495) | 3.39277915 |
| 46 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.37226818 |
| 47 | regulation of early endosome to late endosome transport (GO:2000641) | 3.36624539 |
| 48 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.34770947 |
| 49 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.34354079 |
| 50 | lysine metabolic process (GO:0006553) | 3.31011327 |
| 51 | lysine catabolic process (GO:0006554) | 3.31011327 |
| 52 | negative regulation of phagocytosis (GO:0050765) | 3.30459678 |
| 53 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.29762753 |
| 54 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.27952936 |
| 55 | neutrophil activation involved in immune response (GO:0002283) | 3.25214454 |
| 56 | negative regulation of fibrinolysis (GO:0051918) | 3.24527137 |
| 57 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.18177787 |
| 58 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.18114850 |
| 59 | sodium ion export (GO:0071436) | 3.17644851 |
| 60 | aspartate family amino acid catabolic process (GO:0009068) | 3.15682604 |
| 61 | cellular modified amino acid catabolic process (GO:0042219) | 3.14697408 |
| 62 | glycine metabolic process (GO:0006544) | 3.12359727 |
| 63 | glutamate metabolic process (GO:0006536) | 3.10754440 |
| 64 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.07391607 |
| 65 | B cell receptor signaling pathway (GO:0050853) | 3.06395803 |
| 66 | positive regulation of Rap GTPase activity (GO:0032854) | 3.04491988 |
| 67 | serine family amino acid biosynthetic process (GO:0009070) | 3.03958304 |
| 68 | regulation of mast cell degranulation (GO:0043304) | 3.03808936 |
| 69 | tolerance induction (GO:0002507) | 3.03753456 |
| 70 | response to peptidoglycan (GO:0032494) | 3.03027780 |
| 71 | signal complex assembly (GO:0007172) | 3.02539676 |
| 72 | NADPH regeneration (GO:0006740) | 3.01537429 |
| 73 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.01229636 |
| 74 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.00697126 |
| 75 | response to laminar fluid shear stress (GO:0034616) | 2.99803418 |
| 76 | regulation of leukocyte degranulation (GO:0043300) | 2.99720640 |
| 77 | serine family amino acid metabolic process (GO:0009069) | 2.96376581 |
| 78 | cellular ketone body metabolic process (GO:0046950) | 2.95176011 |
| 79 | regulation of ARF protein signal transduction (GO:0032012) | 2.92762240 |
| 80 | NIK/NF-kappaB signaling (GO:0038061) | 2.92232391 |
| 81 | modulation by virus of host process (GO:0019054) | 2.92160696 |
| 82 | serine family amino acid catabolic process (GO:0009071) | 2.91546917 |
| 83 | response to interleukin-15 (GO:0070672) | 2.91253362 |
| 84 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.91080332 |
| 85 | T cell migration (GO:0072678) | 2.90103305 |
| 86 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.89628792 |
| 87 | heme transport (GO:0015886) | 2.88750897 |
| 88 | acetyl-CoA metabolic process (GO:0006084) | 2.88636069 |
| 89 | DNA deamination (GO:0045006) | 2.87220535 |
| 90 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.86939075 |
| 91 | detection of external biotic stimulus (GO:0098581) | 2.86249761 |
| 92 | negative regulation of interleukin-12 production (GO:0032695) | 2.86111212 |
| 93 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.85460709 |
| 94 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.84887644 |
| 95 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.84887644 |
| 96 | ethanol oxidation (GO:0006069) | 2.83508840 |
| 97 | bile acid biosynthetic process (GO:0006699) | 2.83465342 |
| 98 | aromatic amino acid family catabolic process (GO:0009074) | 2.83052146 |
| 99 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.82730545 |
| 100 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.82730545 |
| 101 | modulation by symbiont of host cellular process (GO:0044068) | 2.81999454 |
| 102 | positive regulation of histone deacetylation (GO:0031065) | 2.81416039 |
| 103 | germinal center formation (GO:0002467) | 2.80392099 |
| 104 | response to mercury ion (GO:0046689) | 2.80347189 |
| 105 | high-density lipoprotein particle remodeling (GO:0034375) | 2.79711643 |
| 106 | sexual reproduction (GO:0019953) | 2.79098555 |
| 107 | regulation of T cell tolerance induction (GO:0002664) | 2.78054914 |
| 108 | urea cycle (GO:0000050) | 2.75794990 |
| 109 | urea metabolic process (GO:0019627) | 2.75794990 |
| 110 | locomotory exploration behavior (GO:0035641) | 2.75358602 |
| 111 | 2-oxoglutarate metabolic process (GO:0006103) | 2.75050055 |
| 112 | galactose catabolic process (GO:0019388) | 2.74623420 |
| 113 | nucleotide salvage (GO:0043173) | 2.74599902 |
| 114 | sterol catabolic process (GO:0016127) | 2.73575264 |
| 115 | cholesterol catabolic process (GO:0006707) | 2.73575264 |
| 116 | cellular extravasation (GO:0045123) | 2.72844247 |
| 117 | phosphate ion transmembrane transport (GO:0035435) | 2.72098917 |
| 118 | acylglycerol catabolic process (GO:0046464) | 2.72070755 |
| 119 | neutral lipid catabolic process (GO:0046461) | 2.72070755 |
| 120 | regulation of extracellular matrix disassembly (GO:0010715) | 2.69748557 |
| 121 | glutamate secretion (GO:0014047) | 2.69358843 |
| 122 | kynurenine metabolic process (GO:0070189) | 2.68765681 |
| 123 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.67624580 |
| 124 | regulation of triglyceride catabolic process (GO:0010896) | 2.67288972 |
| 125 | layer formation in cerebral cortex (GO:0021819) | 2.66980969 |
| 126 | response to type I interferon (GO:0034340) | 2.66809863 |
| 127 | regulation of ARF GTPase activity (GO:0032312) | 2.65760002 |
| 128 | flavonoid metabolic process (GO:0009812) | 2.65681814 |
| 129 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.63416309 |
| 130 | ethanol metabolic process (GO:0006067) | 2.63109579 |
| 131 | type I interferon signaling pathway (GO:0060337) | 2.62766279 |
| 132 | cellular response to type I interferon (GO:0071357) | 2.62766279 |
| 133 | L-serine metabolic process (GO:0006563) | 2.61696448 |
| 134 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.61367454 |
| 135 | amino-acid betaine metabolic process (GO:0006577) | 2.60808825 |
| 136 | 4-hydroxyproline metabolic process (GO:0019471) | 2.60513703 |
| 137 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.60409619 |
| 138 | regulation of regulated secretory pathway (GO:1903305) | 2.60287034 |
| 139 | nitrogen cycle metabolic process (GO:0071941) | 2.60216046 |
| 140 | immunoglobulin mediated immune response (GO:0016064) | 2.60052676 |
| 141 | activated T cell proliferation (GO:0050798) | 2.60047437 |
| 142 | regulation of defense response to virus by virus (GO:0050690) | 2.59766773 |
| 143 | negative regulation of innate immune response (GO:0045824) | 2.59029140 |
| 144 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.58987264 |
| 145 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.58943578 |
| 146 | dicarboxylic acid catabolic process (GO:0043649) | 2.58899827 |
| 147 | regulation of translational termination (GO:0006449) | 2.58258439 |
| 148 | positive regulation of B cell differentiation (GO:0045579) | 2.57627750 |
| 149 | iron coordination entity transport (GO:1901678) | 2.57193912 |
| 150 | myeloid cell activation involved in immune response (GO:0002275) | 2.55991213 |
| 151 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.55505557 |
| 152 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.54617139 |
| 153 | negative regulation of T cell mediated immunity (GO:0002710) | 2.54616342 |
| 154 | positive regulation of lamellipodium assembly (GO:0010592) | 2.54147559 |
| 155 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.53963373 |
| 156 | plasma lipoprotein particle clearance (GO:0034381) | 2.53610398 |
| 157 | barbed-end actin filament capping (GO:0051016) | 2.53238104 |
| 158 | negative regulation of lipid transport (GO:0032369) | 2.52887269 |
| 159 | cellular amino acid catabolic process (GO:0009063) | 2.52745213 |
| 160 | tricarboxylic acid metabolic process (GO:0072350) | 2.51792295 |
| 161 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.51654087 |
| 162 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.51470385 |
| 163 | regulation of fatty acid oxidation (GO:0046320) | 2.51400805 |
| 164 | short-chain fatty acid metabolic process (GO:0046459) | 2.51192094 |
| 165 | cellular response to interleukin-15 (GO:0071350) | 2.50893896 |
| 166 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.50887218 |
| 167 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.50754328 |
| 168 | protein insertion into membrane (GO:0051205) | 2.50607224 |
| 169 | regulation of B cell differentiation (GO:0045577) | 2.50226601 |
| 170 | viral transcription (GO:0019083) | 2.50201690 |
| 171 | alpha-amino acid catabolic process (GO:1901606) | 2.50195423 |
| 172 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.50022805 |
| 173 | activation of protein kinase A activity (GO:0034199) | 2.49473907 |
| 174 | protein localization to endosome (GO:0036010) | 2.48570155 |
| 175 | phosphate ion transport (GO:0006817) | 2.48120824 |
| 176 | detection of biotic stimulus (GO:0009595) | 2.47305986 |
| 177 | negative regulation of type 2 immune response (GO:0002829) | 2.46054247 |
| 178 | myeloid dendritic cell differentiation (GO:0043011) | 2.45801870 |
| 179 | triglyceride catabolic process (GO:0019433) | 2.45701099 |
| 180 | regulation of cholesterol esterification (GO:0010872) | 2.44983443 |
| 181 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.44964879 |
| 182 | ketone body metabolic process (GO:1902224) | 2.44962846 |
| 183 | regulation of cholesterol metabolic process (GO:0090181) | 2.44585720 |
| 184 | protein retention in ER lumen (GO:0006621) | 2.44400270 |
| 185 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.43852577 |
| 186 | regulation of fibrinolysis (GO:0051917) | 2.43832260 |
| 187 | regulation of macrophage cytokine production (GO:0010935) | 2.43323081 |
| 188 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.43293598 |
| 189 | regulation of Rap GTPase activity (GO:0032317) | 2.42986086 |
| 190 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.42650717 |
| 191 | regulation of tolerance induction (GO:0002643) | 2.42453881 |
| 192 | activation of JUN kinase activity (GO:0007257) | 2.41716466 |
| 193 | defense response to protozoan (GO:0042832) | 2.41096341 |
| 194 | response to host immune response (GO:0052572) | 2.40346137 |
| 195 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.40346137 |
| 196 | positive regulation of protein deacetylation (GO:0090312) | 2.40178340 |
| 197 | positive regulation of protein dephosphorylation (GO:0035307) | 2.37857093 |
| 198 | respiratory burst (GO:0045730) | 2.36622708 |
| 199 | response to host defenses (GO:0052200) | 2.35886708 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.17628376 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.47657190 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.95652124 |
| 4 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.86867056 |
| 5 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.84070459 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.82663608 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.79480374 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 2.49637478 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.30255774 |
| 10 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.25188454 |
| 11 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.17616024 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.14147933 |
| 13 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.13709186 |
| 14 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.13686806 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.13652947 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.09225112 |
| 17 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.07514502 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.05150852 |
| 19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.04732226 |
| 20 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.01787134 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.99862219 |
| 22 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.92213031 |
| 23 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.91243929 |
| 24 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.90622628 |
| 25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.83711846 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.82305148 |
| 27 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.82085612 |
| 28 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.80531371 |
| 29 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.78168407 |
| 30 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.77005165 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.76343291 |
| 32 | P68_20966046_ChIP-Seq_HELA_Human | 1.75944371 |
| 33 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.74304949 |
| 34 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.72080256 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.68989161 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68391788 |
| 37 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.67024578 |
| 38 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.63511649 |
| 39 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.61165850 |
| 40 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60921269 |
| 41 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.60315363 |
| 42 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58759328 |
| 43 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.58620097 |
| 44 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.57575219 |
| 45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.57499204 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.56824299 |
| 47 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.56032837 |
| 48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56012654 |
| 49 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.55892562 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.54084770 |
| 51 | KDM2B_26808549_Chip-Seq_K562_Human | 1.53281765 |
| 52 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.53233212 |
| 53 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48359286 |
| 54 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.47372084 |
| 55 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.47308810 |
| 56 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.46994631 |
| 57 | ATF3_27146783_Chip-Seq_COLON_Human | 1.45107355 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43906652 |
| 59 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.42927184 |
| 60 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.40576238 |
| 61 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.39031839 |
| 62 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.38337627 |
| 63 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.37650313 |
| 64 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.37354567 |
| 65 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.36258750 |
| 66 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.35042436 |
| 67 | SA1_27219007_Chip-Seq_Bcells_Human | 1.34966182 |
| 68 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.34760052 |
| 69 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.34446415 |
| 70 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34116887 |
| 71 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.33826637 |
| 72 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.33657361 |
| 73 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.33161101 |
| 74 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.32442480 |
| 75 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.30687052 |
| 76 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.29591902 |
| 77 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.29221975 |
| 78 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.28786096 |
| 79 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.28711520 |
| 80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27449749 |
| 81 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.27218458 |
| 82 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.26435535 |
| 83 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.26342942 |
| 84 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.25502319 |
| 85 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.23419169 |
| 86 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.23321832 |
| 87 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.22773541 |
| 88 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22266458 |
| 89 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.22030737 |
| 90 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21201911 |
| 91 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.20481242 |
| 92 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.20165987 |
| 93 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.20081224 |
| 94 | MAF_26560356_Chip-Seq_TH2_Human | 1.19680900 |
| 95 | UTX_26944678_Chip-Seq_JUKART_Human | 1.19563372 |
| 96 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19562776 |
| 97 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.19337946 |
| 98 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.18820790 |
| 99 | MAF_26560356_Chip-Seq_TH1_Human | 1.18516718 |
| 100 | MYB_26560356_Chip-Seq_TH1_Human | 1.18513000 |
| 101 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17190578 |
| 102 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.16841157 |
| 103 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.16806713 |
| 104 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16754572 |
| 105 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16705807 |
| 106 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.15988462 |
| 107 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.15919306 |
| 108 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.14854372 |
| 109 | MYB_26560356_Chip-Seq_TH2_Human | 1.14506759 |
| 110 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12450880 |
| 111 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11908615 |
| 112 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.10343612 |
| 113 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.10160525 |
| 114 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09249940 |
| 115 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09040878 |
| 116 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08644823 |
| 117 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08327870 |
| 118 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.07979711 |
| 119 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07306483 |
| 120 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.07067347 |
| 121 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.06845891 |
| 122 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.06313130 |
| 123 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.06113562 |
| 124 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05793780 |
| 125 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05228906 |
| 126 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.04846965 |
| 127 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.04797039 |
| 128 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03758053 |
| 129 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.03613567 |
| 130 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.03288993 |
| 131 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98728601 |
| 132 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.97874628 |
| 133 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.97661126 |
| 134 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97273192 |
| 135 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97144864 |
| 136 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.96323922 |
| 137 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.96254069 |
| 138 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.95738691 |
| 139 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94134807 |
| 140 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.93688885 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 4.60391598 |
| 2 | MP0005360_urolithiasis | 4.55544024 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.20710508 |
| 4 | MP0003436_decreased_susceptibility_to | 3.82516796 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.44224021 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.32824277 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 3.20774365 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.91277479 |
| 9 | MP0005365_abnormal_bile_salt | 2.85764016 |
| 10 | MP0003724_increased_susceptibility_to | 2.83208585 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.76667091 |
| 12 | MP0003329_amyloid_beta_deposits | 2.60595919 |
| 13 | MP0006082_CNS_inflammation | 2.59171221 |
| 14 | MP0005671_abnormal_response_to | 2.58450142 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.57697208 |
| 16 | MP0008875_abnormal_xenobiotic_pharmacok | 2.54588445 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 2.51174993 |
| 18 | MP0005083_abnormal_biliary_tract | 2.49009932 |
| 19 | MP0003172_abnormal_lysosome_physiology | 2.44553667 |
| 20 | MP0001800_abnormal_humoral_immune | 2.42630587 |
| 21 | MP0005000_abnormal_immune_tolerance | 2.42333853 |
| 22 | MP0001835_abnormal_antigen_presentation | 2.42188189 |
| 23 | MP0005025_abnormal_response_to | 2.37491544 |
| 24 | MP0002419_abnormal_innate_immunity | 2.34656649 |
| 25 | MP0001790_abnormal_immune_system | 2.30788427 |
| 26 | MP0005387_immune_system_phenotype | 2.30788427 |
| 27 | MP0010329_abnormal_lipoprotein_level | 2.29236543 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 2.16656910 |
| 29 | MP0002420_abnormal_adaptive_immunity | 2.10955408 |
| 30 | MP0002723_abnormal_immune_serum | 2.10830337 |
| 31 | MP0004947_skin_inflammation | 2.10721261 |
| 32 | MP0003303_peritoneal_inflammation | 2.10676646 |
| 33 | MP0001819_abnormal_immune_cell | 2.08258520 |
| 34 | MP0002822_catalepsy | 2.06292663 |
| 35 | MP0002452_abnormal_antigen_presenting | 2.03869992 |
| 36 | MP0008260_abnormal_autophagy | 2.03228395 |
| 37 | MP0001666_abnormal_nutrient_absorption | 1.93034826 |
| 38 | MP0004858_abnormal_nervous_system | 1.92691426 |
| 39 | MP0003252_abnormal_bile_duct | 1.90280226 |
| 40 | MP0005332_abnormal_amino_acid | 1.84835638 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.84047916 |
| 42 | MP0003690_abnormal_glial_cell | 1.83883966 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.81601061 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.80718917 |
| 45 | MP0009785_altered_susceptibility_to | 1.75556048 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.74447251 |
| 47 | MP0001873_stomach_inflammation | 1.73910111 |
| 48 | MP0002398_abnormal_bone_marrow | 1.69734327 |
| 49 | MP0000604_amyloidosis | 1.67850124 |
| 50 | MP0003075_altered_response_to | 1.66277279 |
| 51 | MP0002405_respiratory_system_inflammati | 1.65311301 |
| 52 | MP0000716_abnormal_immune_system | 1.63532701 |
| 53 | MP0002909_abnormal_adrenal_gland | 1.61482704 |
| 54 | MP0002118_abnormal_lipid_homeostasis | 1.59983538 |
| 55 | MP0005410_abnormal_fertilization | 1.57971589 |
| 56 | MP0005167_abnormal_blood-brain_barrier | 1.56775108 |
| 57 | MP0002933_joint_inflammation | 1.54705057 |
| 58 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54240335 |
| 59 | MP0000858_altered_metastatic_potential | 1.53732899 |
| 60 | MP0002148_abnormal_hypersensitivity_rea | 1.50933122 |
| 61 | MP0001851_eye_inflammation | 1.50563665 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.50034883 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 1.49560076 |
| 64 | MP0004130_abnormal_muscle_cell | 1.48275482 |
| 65 | MP0003279_aneurysm | 1.47996208 |
| 66 | MP0006036_abnormal_mitochondrial_physio | 1.47831785 |
| 67 | MP0004381_abnormal_hair_follicle | 1.46744734 |
| 68 | MP0000609_abnormal_liver_physiology | 1.45156611 |
| 69 | MP0003635_abnormal_synaptic_transmissio | 1.43193239 |
| 70 | MP0000703_abnormal_thymus_morphology | 1.41216276 |
| 71 | MP0000747_muscle_weakness | 1.39753041 |
| 72 | MP0008961_abnormal_basal_metabolism | 1.37306824 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 1.37122675 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 1.34878671 |
| 75 | MP0002722_abnormal_immune_system | 1.32647636 |
| 76 | MP0001845_abnormal_inflammatory_respons | 1.32279601 |
| 77 | MP0002429_abnormal_blood_cell | 1.32004869 |
| 78 | MP0003879_abnormal_hair_cell | 1.29485027 |
| 79 | MP0003183_abnormal_peptide_metabolism | 1.28928910 |
| 80 | MP0002089_abnormal_postnatal_growth/wei | 1.27692409 |
| 81 | MP0005319_abnormal_enzyme/_coenzyme | 1.26466552 |
| 82 | MP0003828_pulmonary_edema | 1.25459721 |
| 83 | MP0000689_abnormal_spleen_morphology | 1.24490532 |
| 84 | MP0004270_analgesia | 1.21619292 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 1.16030875 |
| 86 | MP0001348_abnormal_lacrimal_gland | 1.15969980 |
| 87 | MP0009643_abnormal_urine_homeostasis | 1.15757858 |
| 88 | MP0005076_abnormal_cell_differentiation | 1.14460376 |
| 89 | MP0003195_calcinosis | 1.12657161 |
| 90 | MP0003091_abnormal_cell_migration | 1.12621409 |
| 91 | MP0002396_abnormal_hematopoietic_system | 1.09739652 |
| 92 | MP0003866_abnormal_defecation | 1.08873842 |
| 93 | MP0004019_abnormal_vitamin_homeostasis | 1.08465950 |
| 94 | MP0005166_decreased_susceptibility_to | 1.08215902 |
| 95 | MP0008469_abnormal_protein_level | 1.08004669 |
| 96 | MP0005409_darkened_coat_color | 1.07997723 |
| 97 | MP0008874_decreased_physiological_sensi | 1.06880302 |
| 98 | MP0005310_abnormal_salivary_gland | 1.06544600 |
| 99 | MP0004185_abnormal_adipocyte_glucose | 1.06030232 |
| 100 | MP0001849_ear_inflammation | 1.05692762 |
| 101 | MP0002269_muscular_atrophy | 1.03719054 |
| 102 | MP0005451_abnormal_body_composition | 1.00854585 |
| 103 | MP0003283_abnormal_digestive_organ | 1.00491497 |
| 104 | MP0001958_emphysema | 0.97828759 |
| 105 | MP0003633_abnormal_nervous_system | 0.96779824 |
| 106 | MP0002063_abnormal_learning/memory/cond | 0.94767323 |
| 107 | MP0000490_abnormal_crypts_of | 0.93656452 |
| 108 | MP0000013_abnormal_adipose_tissue | 0.93561175 |
| 109 | MP0005666_abnormal_adipose_tissue | 0.92706491 |
| 110 | MP0003566_abnormal_cell_adhesion | 0.92405986 |
| 111 | MP0000598_abnormal_liver_morphology | 0.92366543 |
| 112 | MP0000685_abnormal_immune_system | 0.92124916 |
| 113 | MP0005330_cardiomyopathy | 0.91968559 |
| 114 | MP0000678_abnormal_parathyroid_gland | 0.91564663 |
| 115 | MP0010368_abnormal_lymphatic_system | 0.91032837 |
| 116 | MP0003448_altered_tumor_morphology | 0.90369300 |
| 117 | MP0002132_abnormal_respiratory_system | 0.90239610 |
| 118 | MP0005390_skeleton_phenotype | 0.90009234 |
| 119 | MP0004885_abnormal_endolymph | 0.85189401 |
| 120 | MP0000343_altered_response_to | 0.83809989 |
| 121 | MP0002064_seizures | 0.83254749 |
| 122 | MP0002796_impaired_skin_barrier | 0.82826182 |
| 123 | MP0000751_myopathy | 0.81434224 |
| 124 | MP0003638_abnormal_response/metabolism_ | 0.81007509 |
| 125 | MP0003868_abnormal_feces_composition | 0.79444256 |
| 126 | MP0000249_abnormal_blood_vessel | 0.79409516 |
| 127 | MP0005636_abnormal_mineral_homeostasis | 0.79397515 |
| 128 | MP0000767_abnormal_smooth_muscle | 0.78945212 |
| 129 | MP0004811_abnormal_neuron_physiology | 0.78278080 |
| 130 | MP0002653_abnormal_ependyma_morphology | 0.77613792 |
| 131 | MP0008770_decreased_survivor_rate | 0.77592572 |
| 132 | MP0005375_adipose_tissue_phenotype | 0.77451443 |
| 133 | MP0009745_abnormal_behavioral_response | 0.77321347 |
| 134 | MP0001853_heart_inflammation | 0.76119875 |
| 135 | MP0004087_abnormal_muscle_fiber | 0.75950429 |
| 136 | MP0009764_decreased_sensitivity_to | 0.75528667 |
| 137 | MP0003045_fibrosis | 0.74984068 |
| 138 | MP0002733_abnormal_thermal_nociception | 0.74219646 |
| 139 | MP0005381_digestive/alimentary_phenotyp | 0.73375553 |
| 140 | MP0008569_lethality_at_weaning | 0.72566803 |
| 141 | MP0004808_abnormal_hematopoietic_stem | 0.71956482 |
| 142 | MP0004883_abnormal_blood_vessel | 0.71752374 |
| 143 | MP0006035_abnormal_mitochondrial_morpho | 0.70615717 |
| 144 | MP0008872_abnormal_physiological_respon | 0.70046823 |
| 145 | MP0004510_myositis | 0.69595460 |
| 146 | MP0001730_embryonic_growth_arrest | 0.69332211 |
| 147 | MP0000477_abnormal_intestine_morphology | 0.68518684 |
| 148 | MP0002138_abnormal_hepatobiliary_system | 0.67722004 |
| 149 | MP0003795_abnormal_bone_structure | 0.67417512 |
| 150 | MP0005397_hematopoietic_system_phenotyp | 0.66363941 |
| 151 | MP0001545_abnormal_hematopoietic_system | 0.66363941 |
| 152 | MP0005023_abnormal_wound_healing | 0.65753638 |
| 153 | MP0006054_spinal_hemorrhage | 0.64308033 |
| 154 | MP0005058_abnormal_lysosome_morphology | 0.63355569 |
| 155 | MP0009278_abnormal_bone_marrow | 0.62291604 |
| 156 | MP0000920_abnormal_myelination | 0.61777749 |
| 157 | MP0009642_abnormal_blood_homeostasis | 0.61622582 |
| 158 | MP0004145_abnormal_muscle_electrophysio | 0.61308181 |
| 159 | MP0005501_abnormal_skin_physiology | 0.61230782 |
| 160 | MP0004233_abnormal_muscle_weight | 0.60588364 |
| 161 | MP0001765_abnormal_ion_homeostasis | 0.60313364 |
| 162 | MP0005535_abnormal_body_temperature | 0.60077915 |
| 163 | MP0005266_abnormal_metabolism | 0.59524776 |
| 164 | MP0000003_abnormal_adipose_tissue | 0.58583511 |
| 165 | MP0001663_abnormal_digestive_system | 0.58004020 |
| 166 | MP0000358_abnormal_cell_content/ | 0.56302646 |
| 167 | MP0002078_abnormal_glucose_homeostasis | 0.55721228 |
| 168 | MP0001756_abnormal_urination | 0.55129617 |
| 169 | MP0001970_abnormal_pain_threshold | 0.54593258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.47097935 |
| 2 | Abnormality of the Achilles tendon (HP:0005109) | 4.14355058 |
| 3 | Deep venous thrombosis (HP:0002625) | 4.13401222 |
| 4 | Achilles tendon contracture (HP:0001771) | 4.04143149 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.88637079 |
| 6 | Abnormality of macrophages (HP:0004311) | 3.78797491 |
| 7 | Recurrent abscess formation (HP:0002722) | 3.74152371 |
| 8 | Xanthomatosis (HP:0000991) | 3.72288649 |
| 9 | Myokymia (HP:0002411) | 3.69616704 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 3.59084136 |
| 11 | Obstructive sleep apnea (HP:0002870) | 3.43685387 |
| 12 | Increased IgE level (HP:0003212) | 3.34845563 |
| 13 | Cellulitis (HP:0100658) | 3.33787833 |
| 14 | Myositis (HP:0100614) | 3.25904575 |
| 15 | Obstructive lung disease (HP:0006536) | 3.13150559 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 3.13150559 |
| 17 | Polycythemia (HP:0001901) | 3.11568542 |
| 18 | Spontaneous hematomas (HP:0007420) | 3.09505604 |
| 19 | Hyperlipoproteinemia (HP:0010980) | 3.09228038 |
| 20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.04351143 |
| 21 | Abnormality of the lower motor neuron (HP:0002366) | 2.97401277 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 2.87694993 |
| 23 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.84381934 |
| 24 | Hyperammonemia (HP:0001987) | 2.83337057 |
| 25 | Meningitis (HP:0001287) | 2.81456865 |
| 26 | Hypobetalipoproteinemia (HP:0003563) | 2.80035278 |
| 27 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.79616836 |
| 28 | Gingivitis (HP:0000230) | 2.75590689 |
| 29 | Orchitis (HP:0100796) | 2.73393487 |
| 30 | Supranuclear gaze palsy (HP:0000605) | 2.72584692 |
| 31 | Recurrent fungal infections (HP:0002841) | 2.71515443 |
| 32 | Gastrointestinal infarctions (HP:0005244) | 2.69170344 |
| 33 | Prolonged bleeding time (HP:0003010) | 2.68367677 |
| 34 | Dysostosis multiplex (HP:0000943) | 2.62962977 |
| 35 | Colitis (HP:0002583) | 2.61283324 |
| 36 | Pustule (HP:0200039) | 2.60940759 |
| 37 | Gastrointestinal inflammation (HP:0004386) | 2.58824945 |
| 38 | Ketosis (HP:0001946) | 2.58499195 |
| 39 | Gout (HP:0001997) | 2.58196662 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.50610581 |
| 41 | Gastrointestinal stroma tumor (HP:0100723) | 2.49268172 |
| 42 | Cerebral aneurysm (HP:0004944) | 2.44654951 |
| 43 | Insomnia (HP:0100785) | 2.44370409 |
| 44 | Inflammation of the large intestine (HP:0002037) | 2.43877330 |
| 45 | Intrahepatic cholestasis (HP:0001406) | 2.43720596 |
| 46 | Difficulty climbing stairs (HP:0003551) | 2.41241074 |
| 47 | Purpura (HP:0000979) | 2.40646658 |
| 48 | Myoglobinuria (HP:0002913) | 2.35571809 |
| 49 | Upper limb amyotrophy (HP:0009129) | 2.34999851 |
| 50 | Distal upper limb amyotrophy (HP:0007149) | 2.34999851 |
| 51 | Ankle clonus (HP:0011448) | 2.34385716 |
| 52 | Broad face (HP:0000283) | 2.33129409 |
| 53 | Emphysema (HP:0002097) | 2.32941857 |
| 54 | Delayed CNS myelination (HP:0002188) | 2.31983677 |
| 55 | Visual hallucinations (HP:0002367) | 2.30299829 |
| 56 | Annular pancreas (HP:0001734) | 2.29202532 |
| 57 | Vasculitis (HP:0002633) | 2.28522718 |
| 58 | Multiple enchondromatosis (HP:0005701) | 2.27742129 |
| 59 | Neonatal onset (HP:0003623) | 2.26678530 |
| 60 | Increased cerebral lipofuscin (HP:0011813) | 2.26665859 |
| 61 | Recurrent viral infections (HP:0004429) | 2.26244188 |
| 62 | Spastic diplegia (HP:0001264) | 2.25023221 |
| 63 | Malnutrition (HP:0004395) | 2.24975277 |
| 64 | Recurrent skin infections (HP:0001581) | 2.24706732 |
| 65 | Cerebral inclusion bodies (HP:0100314) | 2.24700067 |
| 66 | Global brain atrophy (HP:0002283) | 2.24421804 |
| 67 | Thin bony cortex (HP:0002753) | 2.23852905 |
| 68 | Hyperglycinuria (HP:0003108) | 2.23762003 |
| 69 | Agammaglobulinemia (HP:0004432) | 2.23666604 |
| 70 | Abnormality of the fingertips (HP:0001211) | 2.21032839 |
| 71 | Cholecystitis (HP:0001082) | 2.20692874 |
| 72 | Abnormal gallbladder physiology (HP:0012438) | 2.20692874 |
| 73 | Epistaxis (HP:0000421) | 2.20182978 |
| 74 | Retrobulbar optic neuritis (HP:0100654) | 2.20048461 |
| 75 | Optic neuritis (HP:0100653) | 2.20048461 |
| 76 | Hypolipoproteinemia (HP:0010981) | 2.18922726 |
| 77 | Abnormality of glycolipid metabolism (HP:0010969) | 2.18586742 |
| 78 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.18586742 |
| 79 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.18586742 |
| 80 | Ragged-red muscle fibers (HP:0003200) | 2.17327572 |
| 81 | Craniofacial dystonia (HP:0012179) | 2.17224577 |
| 82 | Abnormality of glycine metabolism (HP:0010895) | 2.15386702 |
| 83 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.15386702 |
| 84 | Torticollis (HP:0000473) | 2.14470887 |
| 85 | Reticulocytosis (HP:0001923) | 2.13760727 |
| 86 | Angiofibromas (HP:0010615) | 2.13484427 |
| 87 | Adenoma sebaceum (HP:0009720) | 2.13484427 |
| 88 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.12337165 |
| 89 | Hypertensive crisis (HP:0100735) | 2.11550986 |
| 90 | Focal dystonia (HP:0004373) | 2.11260598 |
| 91 | Panhypogammaglobulinemia (HP:0003139) | 2.10320943 |
| 92 | Encephalitis (HP:0002383) | 2.08647202 |
| 93 | Slow saccadic eye movements (HP:0000514) | 2.08448451 |
| 94 | Deep palmar crease (HP:0006191) | 2.06163282 |
| 95 | Ileus (HP:0002595) | 2.05354448 |
| 96 | Systemic lupus erythematosus (HP:0002725) | 2.05184861 |
| 97 | Stomatitis (HP:0010280) | 2.03867390 |
| 98 | Neuronal loss in central nervous system (HP:0002529) | 2.02053642 |
| 99 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.01965370 |
| 100 | Progressive muscle weakness (HP:0003323) | 2.01818405 |
| 101 | Hemorrhage of the eye (HP:0011885) | 2.01630916 |
| 102 | Hypoalphalipoproteinemia (HP:0003233) | 2.00864599 |
| 103 | Easy fatigability (HP:0003388) | 2.00817459 |
| 104 | Chest pain (HP:0100749) | 1.99334329 |
| 105 | Spastic tetraparesis (HP:0001285) | 1.98251591 |
| 106 | Protrusio acetabuli (HP:0003179) | 1.97710354 |
| 107 | Urticaria (HP:0001025) | 1.97303228 |
| 108 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.96702436 |
| 109 | Neurofibrillary tangles (HP:0002185) | 1.96662818 |
| 110 | Axonal loss (HP:0003447) | 1.95937123 |
| 111 | Increased variability in muscle fiber diameter (HP:0003557) | 1.95861502 |
| 112 | Hand muscle atrophy (HP:0009130) | 1.95594574 |
| 113 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.94058178 |
| 114 | Late onset (HP:0003584) | 1.94029507 |
| 115 | Delusions (HP:0000746) | 1.93229083 |
| 116 | Hyperglycinemia (HP:0002154) | 1.93177934 |
| 117 | Hypochromic anemia (HP:0001931) | 1.93136795 |
| 118 | Hyperacusis (HP:0010780) | 1.92934179 |
| 119 | Increased connective tissue (HP:0009025) | 1.92303394 |
| 120 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.92067162 |
| 121 | Ketoacidosis (HP:0001993) | 1.90549536 |
| 122 | Lymphopenia (HP:0001888) | 1.90531198 |
| 123 | Papilledema (HP:0001085) | 1.90385232 |
| 124 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.90124464 |
| 125 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.89861000 |
| 126 | Restrictive lung disease (HP:0002091) | 1.89824784 |
| 127 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.89647845 |
| 128 | Mucopolysacchariduria (HP:0008155) | 1.89647845 |
| 129 | Hypertriglyceridemia (HP:0002155) | 1.89529933 |
| 130 | Petechiae (HP:0000967) | 1.89336020 |
| 131 | Increased serum ferritin (HP:0003281) | 1.89275403 |
| 132 | Lymphangioma (HP:0100764) | 1.88976648 |
| 133 | Distal lower limb amyotrophy (HP:0008944) | 1.88322679 |
| 134 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.87996669 |
| 135 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.87996669 |
| 136 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.87996669 |
| 137 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.87989632 |
| 138 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.87285609 |
| 139 | Amyotrophic lateral sclerosis (HP:0007354) | 1.86907488 |
| 140 | Cholelithiasis (HP:0001081) | 1.86209838 |
| 141 | Increased IgM level (HP:0003496) | 1.86075373 |
| 142 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.85688079 |
| 143 | Status epilepticus (HP:0002133) | 1.84960980 |
| 144 | Abnormality of the nasal mucosa (HP:0000433) | 1.84575099 |
| 145 | Hypergammaglobulinemia (HP:0010702) | 1.83973129 |
| 146 | Granulocytopenia (HP:0001913) | 1.83589225 |
| 147 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.82906620 |
| 148 | Hyperbilirubinemia (HP:0002904) | 1.82809882 |
| 149 | Dicarboxylic aciduria (HP:0003215) | 1.82752054 |
| 150 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.82752054 |
| 151 | Pulmonary infiltrates (HP:0002113) | 1.82718732 |
| 152 | Genu recurvatum (HP:0002816) | 1.82404710 |
| 153 | Disproportionate tall stature (HP:0001519) | 1.82240501 |
| 154 | Hypercortisolism (HP:0001578) | 1.81558101 |
| 155 | Postural instability (HP:0002172) | 1.81402417 |
| 156 | Amyloidosis (HP:0011034) | 1.81374861 |
| 157 | Abnormal social behavior (HP:0012433) | 1.81361167 |
| 158 | Impaired social interactions (HP:0000735) | 1.81361167 |
| 159 | Ventricular fibrillation (HP:0001663) | 1.81312753 |
| 160 | Seborrheic dermatitis (HP:0001051) | 1.81011473 |
| 161 | Abnormal cartilage morphology (HP:0002763) | 1.80913485 |
| 162 | Interstitial pulmonary disease (HP:0006530) | 1.80811048 |
| 163 | Urinary urgency (HP:0000012) | 1.80472936 |
| 164 | Stridor (HP:0010307) | 1.80178533 |
| 165 | Acanthocytosis (HP:0001927) | 1.80038369 |
| 166 | Diplopia (HP:0000651) | 1.79790384 |
| 167 | Abnormality of binocular vision (HP:0011514) | 1.79790384 |
| 168 | Depression (HP:0000716) | 1.79588797 |
| 169 | Generalized hyperpigmentation (HP:0007440) | 1.79117381 |
| 170 | Loss of speech (HP:0002371) | 1.79045436 |
| 171 | Osteomyelitis (HP:0002754) | 1.79020162 |
| 172 | Hemiplegia (HP:0002301) | 1.76751332 |
| 173 | Sensorimotor neuropathy (HP:0007141) | 1.76737752 |
| 174 | Rapidly progressive (HP:0003678) | 1.76592788 |
| 175 | Papilloma (HP:0012740) | 1.76457752 |
| 176 | Verrucae (HP:0200043) | 1.76457752 |
| 177 | Athetosis (HP:0002305) | 1.74604638 |
| 178 | Irritability (HP:0000737) | 1.74252154 |
| 179 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.73891319 |
| 180 | Muscle stiffness (HP:0003552) | 1.72774223 |
| 181 | Intention tremor (HP:0002080) | 1.72101456 |
| 182 | Abnormal number of erythroid precursors (HP:0012131) | 1.71995484 |
| 183 | Myopathic facies (HP:0002058) | 1.71211342 |
| 184 | Difficulty running (HP:0009046) | 1.70782160 |
| 185 | Gastrointestinal dysmotility (HP:0002579) | 1.70418792 |
| 186 | Polygenic inheritance (HP:0010982) | 1.70067008 |
| 187 | Epidermoid cyst (HP:0200040) | 1.69383407 |
| 188 | Nasal polyposis (HP:0100582) | 1.68233401 |
| 189 | Exercise-induced myalgia (HP:0003738) | 1.67645922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.81426604 |
| 2 | PRPF4B | 3.79047980 |
| 3 | PKN2 | 3.73438328 |
| 4 | MAP3K10 | 3.11846049 |
| 5 | RIPK4 | 2.81657396 |
| 6 | ERN1 | 2.60389283 |
| 7 | SCYL2 | 2.29279745 |
| 8 | PRKD3 | 2.27543375 |
| 9 | TAOK1 | 2.26496409 |
| 10 | EEF2K | 2.24838677 |
| 11 | KSR2 | 2.16346722 |
| 12 | MAP3K13 | 2.14430254 |
| 13 | MAP3K11 | 2.12901304 |
| 14 | MAP3K9 | 2.05104645 |
| 15 | BCKDK | 2.03176827 |
| 16 | ICK | 2.02813471 |
| 17 | SMG1 | 1.97371694 |
| 18 | KDR | 1.87378207 |
| 19 | GRK6 | 1.83136154 |
| 20 | TYK2 | 1.81837546 |
| 21 | TNK2 | 1.79374727 |
| 22 | FES | 1.75486135 |
| 23 | IRAK4 | 1.66295952 |
| 24 | TESK2 | 1.66087768 |
| 25 | ARAF | 1.65901757 |
| 26 | MAP4K1 | 1.65545099 |
| 27 | DAPK2 | 1.65162693 |
| 28 | CAMKK1 | 1.64293269 |
| 29 | BLK | 1.57381828 |
| 30 | CSK | 1.56325535 |
| 31 | RIPK1 | 1.55489561 |
| 32 | PAK6 | 1.51814425 |
| 33 | LRRK2 | 1.50680587 |
| 34 | TESK1 | 1.50553998 |
| 35 | NME2 | 1.48626110 |
| 36 | EPHB1 | 1.42124780 |
| 37 | MAP2K2 | 1.40185491 |
| 38 | MAP3K7 | 1.37345954 |
| 39 | BTK | 1.31621463 |
| 40 | TYRO3 | 1.27272614 |
| 41 | TAOK2 | 1.24465114 |
| 42 | MAP3K3 | 1.23878816 |
| 43 | IRAK3 | 1.23600536 |
| 44 | ILK | 1.17819924 |
| 45 | JAK3 | 1.17052310 |
| 46 | EPHA4 | 1.14529890 |
| 47 | CDC42BPA | 1.14336073 |
| 48 | PTK6 | 1.13319627 |
| 49 | CDK19 | 1.12900346 |
| 50 | MAP3K14 | 1.08929223 |
| 51 | DAPK3 | 1.08203069 |
| 52 | NTRK1 | 1.07183903 |
| 53 | HCK | 1.05832219 |
| 54 | RAF1 | 1.02153339 |
| 55 | CDK12 | 1.02149727 |
| 56 | JAK1 | 1.00065308 |
| 57 | MINK1 | 0.98496610 |
| 58 | PDPK1 | 0.95801119 |
| 59 | PDK1 | 0.95161577 |
| 60 | SYK | 0.94808169 |
| 61 | DAPK1 | 0.93723453 |
| 62 | SIK3 | 0.92633636 |
| 63 | ITK | 0.91487760 |
| 64 | NEK1 | 0.90997209 |
| 65 | BMX | 0.90583601 |
| 66 | MAP2K3 | 0.89783904 |
| 67 | MAP3K1 | 0.88117250 |
| 68 | DYRK1B | 0.87311147 |
| 69 | LATS2 | 0.83875209 |
| 70 | PDK3 | 0.83352602 |
| 71 | PDK4 | 0.83352602 |
| 72 | RET | 0.83321670 |
| 73 | ALK | 0.82961876 |
| 74 | LCK | 0.82921209 |
| 75 | MAP3K8 | 0.81753071 |
| 76 | PINK1 | 0.81697698 |
| 77 | PAK4 | 0.80036012 |
| 78 | HIPK2 | 0.79297901 |
| 79 | SIK1 | 0.79082297 |
| 80 | RPS6KA2 | 0.75547792 |
| 81 | RPS6KL1 | 0.74850839 |
| 82 | RPS6KC1 | 0.74850839 |
| 83 | TXK | 0.74039024 |
| 84 | MAP3K6 | 0.73043921 |
| 85 | IKBKE | 0.72688595 |
| 86 | MARK3 | 0.71420099 |
| 87 | FGR | 0.70245022 |
| 88 | PRKCH | 0.69056814 |
| 89 | MAPK7 | 0.67813454 |
| 90 | MAP3K2 | 0.64976821 |
| 91 | PIM2 | 0.64572982 |
| 92 | MAP2K1 | 0.64431350 |
| 93 | LYN | 0.63432970 |
| 94 | JAK2 | 0.62795755 |
| 95 | STK11 | 0.62536029 |
| 96 | TGFBR2 | 0.62197176 |
| 97 | IRAK2 | 0.62109935 |
| 98 | MAP2K4 | 0.62092045 |
| 99 | CDK15 | 0.62059755 |
| 100 | CDK14 | 0.61926173 |
| 101 | MAPK11 | 0.61192347 |
| 102 | CDK11A | 0.60444743 |
| 103 | NEK2 | 0.59880568 |
| 104 | MAPK12 | 0.58049896 |
| 105 | RPS6KA6 | 0.58022987 |
| 106 | UHMK1 | 0.57774650 |
| 107 | KIT | 0.57384824 |
| 108 | IKBKB | 0.57129027 |
| 109 | CDK5 | 0.56441594 |
| 110 | PTK2B | 0.56248961 |
| 111 | BRAF | 0.55675673 |
| 112 | DYRK3 | 0.55462835 |
| 113 | STK38 | 0.55289309 |
| 114 | CDK4 | 0.53809351 |
| 115 | MAP2K6 | 0.53064432 |
| 116 | LMTK2 | 0.53039414 |
| 117 | PDGFRA | 0.52748040 |
| 118 | SGK3 | 0.52649582 |
| 119 | PRKG2 | 0.52440171 |
| 120 | CSF1R | 0.52262606 |
| 121 | CDK18 | 0.51645835 |
| 122 | PRKD1 | 0.50385642 |
| 123 | PAK1 | 0.49934822 |
| 124 | MARK2 | 0.49921821 |
| 125 | FYN | 0.49772599 |
| 126 | TBK1 | 0.49564153 |
| 127 | FGFR4 | 0.49194039 |
| 128 | FGFR3 | 0.48891260 |
| 129 | TIE1 | 0.46761976 |
| 130 | SIK2 | 0.46339439 |
| 131 | PHKG2 | 0.45596774 |
| 132 | PHKG1 | 0.45596774 |
| 133 | MAPKAPK3 | 0.45141719 |
| 134 | MTOR | 0.43263696 |
| 135 | MAPK4 | 0.43121149 |
| 136 | TTN | 0.43070233 |
| 137 | CAMK1 | 0.41050543 |
| 138 | ABL2 | 0.40748779 |
| 139 | PTK2 | 0.40742181 |
| 140 | STK10 | 0.40555871 |
| 141 | ZAP70 | 0.39194213 |
| 142 | PRKD2 | 0.39005485 |
| 143 | MOS | 0.38642534 |
| 144 | PRKCZ | 0.37940367 |
| 145 | PAK2 | 0.37634095 |
| 146 | BRSK1 | 0.36459209 |
| 147 | CSNK1G2 | 0.36128117 |
| 148 | NME1 | 0.36121230 |
| 149 | KSR1 | 0.35155373 |
| 150 | MATK | 0.34732735 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.56931235 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.04259693 |
| 3 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.67940237 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.65568360 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.62590313 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.54877035 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.47495124 |
| 8 | Sulfur relay system_Homo sapiens_hsa04122 | 2.45769293 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.26531012 |
| 10 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.24889724 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 2.20144691 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.02250710 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.96730747 |
| 14 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.94591506 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.92057145 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.89747089 |
| 17 | Bile secretion_Homo sapiens_hsa04976 | 1.89345105 |
| 18 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.82179437 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.81761077 |
| 20 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.77575094 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.71845158 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.71612955 |
| 23 | Carbon metabolism_Homo sapiens_hsa01200 | 1.71551629 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.71171352 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.70306484 |
| 26 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.69602629 |
| 27 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.67086375 |
| 28 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.64581593 |
| 29 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.63823773 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.63244431 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.62504139 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.59805443 |
| 33 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.59269101 |
| 34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.57918533 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.51963423 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.48955812 |
| 37 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.44611871 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.44229699 |
| 39 | Tuberculosis_Homo sapiens_hsa05152 | 1.41214642 |
| 40 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.40692330 |
| 41 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.39395988 |
| 42 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.39362014 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33935315 |
| 44 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.33608565 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 1.33508508 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31525679 |
| 47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.29402997 |
| 48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.28992357 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28509478 |
| 50 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.26802441 |
| 51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.25336535 |
| 52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24498680 |
| 53 | Malaria_Homo sapiens_hsa05144 | 1.24364955 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.23409675 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.22049941 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22043512 |
| 57 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.20488901 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.17981500 |
| 59 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17874026 |
| 60 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.17115499 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.16746731 |
| 62 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.13401693 |
| 63 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.12248920 |
| 64 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.11471202 |
| 65 | Measles_Homo sapiens_hsa05162 | 1.09222515 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09035249 |
| 67 | Influenza A_Homo sapiens_hsa05164 | 1.09004357 |
| 68 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.07118521 |
| 69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.06763367 |
| 70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.05402504 |
| 71 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.05176924 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.04573875 |
| 73 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.04228398 |
| 74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03540530 |
| 75 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.02906125 |
| 76 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.02247991 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 1.02071267 |
| 78 | Prion diseases_Homo sapiens_hsa05020 | 1.00520975 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98041985 |
| 80 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.97979048 |
| 81 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.97092836 |
| 82 | Hepatitis B_Homo sapiens_hsa05161 | 0.96835668 |
| 83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.95329787 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.95058768 |
| 85 | Olfactory transduction_Homo sapiens_hsa04740 | 0.95009342 |
| 86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.93864771 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.93571560 |
| 88 | Endometrial cancer_Homo sapiens_hsa05213 | 0.92271810 |
| 89 | Lysosome_Homo sapiens_hsa04142 | 0.92232706 |
| 90 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.91364717 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.91275124 |
| 92 | Apoptosis_Homo sapiens_hsa04210 | 0.90671754 |
| 93 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.90356945 |
| 94 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.89652060 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89378728 |
| 96 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.89137922 |
| 97 | Pertussis_Homo sapiens_hsa05133 | 0.87752767 |
| 98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86955385 |
| 99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.83389437 |
| 100 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80683533 |
| 101 | Long-term potentiation_Homo sapiens_hsa04720 | 0.80530733 |
| 102 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.78656025 |
| 103 | Bladder cancer_Homo sapiens_hsa05219 | 0.78517656 |
| 104 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.78405491 |
| 105 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.78042584 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.77264010 |
| 107 | Phagosome_Homo sapiens_hsa04145 | 0.77227083 |
| 108 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.76983521 |
| 109 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.76652503 |
| 110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.76464989 |
| 111 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.76218798 |
| 112 | Amoebiasis_Homo sapiens_hsa05146 | 0.75323373 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74921617 |
| 114 | Salmonella infection_Homo sapiens_hsa05132 | 0.74906321 |
| 115 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.73712336 |
| 116 | Colorectal cancer_Homo sapiens_hsa05210 | 0.73242330 |
| 117 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.72188141 |
| 118 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.72035731 |
| 119 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.71350185 |
| 120 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.70841641 |
| 121 | Glioma_Homo sapiens_hsa05214 | 0.70673866 |
| 122 | Shigellosis_Homo sapiens_hsa05131 | 0.70623835 |
| 123 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.70095767 |
| 124 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69380351 |
| 125 | Ribosome_Homo sapiens_hsa03010 | 0.68471091 |
| 126 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.67103988 |
| 127 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66172196 |
| 128 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65952279 |
| 129 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.64670518 |
| 130 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64582980 |
| 131 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.63564011 |
| 132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63272743 |
| 133 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62899994 |
| 134 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62894041 |
| 135 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62790355 |
| 136 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.62612751 |
| 137 | Asthma_Homo sapiens_hsa05310 | 0.62337059 |
| 138 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61293365 |
| 139 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60500427 |
| 140 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60070891 |
| 141 | Histidine metabolism_Homo sapiens_hsa00340 | 0.59040253 |
| 142 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.58489028 |
| 143 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58253363 |
| 144 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56884533 |
| 145 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56746463 |
| 146 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55375536 |
| 147 | Thyroid cancer_Homo sapiens_hsa05216 | 0.55131905 |
| 148 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54596966 |
| 149 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53877937 |
| 150 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53733956 |
| 151 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53505510 |
| 152 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51374279 |
| 153 | Gap junction_Homo sapiens_hsa04540 | 0.51189726 |
| 154 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.51066031 |
| 155 | Salivary secretion_Homo sapiens_hsa04970 | 0.49757363 |
| 156 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49740355 |
| 157 | Endocytosis_Homo sapiens_hsa04144 | 0.49096769 |
| 158 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.47789965 |
| 159 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47423759 |
| 160 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47032885 |
| 161 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.46535660 |
| 162 | Insulin resistance_Homo sapiens_hsa04931 | 0.45142375 |
| 163 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.43970195 |
| 164 | Parkinsons disease_Homo sapiens_hsa05012 | 0.43892062 |
| 165 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43617012 |
| 166 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.39699936 |
| 167 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.38561050 |
| 168 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.37963281 |
| 169 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37795984 |
| 170 | Insulin secretion_Homo sapiens_hsa04911 | 0.37520551 |
| 171 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37489402 |
| 172 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.35099191 |
| 173 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.34627064 |
| 174 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.33879460 |
| 175 | GABAergic synapse_Homo sapiens_hsa04727 | 0.33580291 |
| 176 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.33276060 |
| 177 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.32801361 |
| 178 | Circadian entrainment_Homo sapiens_hsa04713 | 0.31510631 |

